Impact of a Central-Line Insertion Site Assessment (CLISA) score on localized insertion site infection to prevent central-line-associated bloodstream infection (CLABSI).
Academic Medical Centers
Adult
Aged
Bacteremia
/ epidemiology
California
/ epidemiology
Catheter-Related Infections
/ epidemiology
Central Venous Catheters
Cross Infection
/ epidemiology
Female
Humans
Incidence
Infection Control
/ methods
Intensive Care Units
Male
Middle Aged
Oncology Service, Hospital
Regression Analysis
Retrospective Studies
Risk Factors
Journal
Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
pubmed:
9
11
2019
medline:
15
12
2020
entrez:
9
11
2019
Statut:
ppublish
Résumé
To assess the impact of a newly developed Central-Line Insertion Site Assessment (CLISA) score on the incidence of local inflammation or infection for CLABSI prevention. A pre- and postintervention, quasi-experimental quality improvement study. Adult inpatients with central venous catheters (CVCs) hospitalized in an intensive care unit or oncology ward at a large academic medical center. We evaluated CLISA score impact on insertion site inflammation and infection (CLISA score of 2 or 3) incidence in the baseline period (June 2014-January 2015) and the intervention period (April 2015-October 2017) using interrupted times series and generalized linear mixed-effects multivariable analyses. These were run separately for days-to-line removal from identification of a CLISA score of 2 or 3. CLISA score interrater reliability and photo quiz results were evaluated. Among 6,957 CVCs assessed 40,846 times, percentage of lines with CLISA score of 2 or 3 in the baseline and intervention periods decreased by 78.2% (from 22.0% to 4.7%), with a significant immediate decrease in the time-series analysis (P < .001). According to the multivariable regression, the intervention was associated with lower percentage of lines with a CLISA score of 2 or 3, after adjusting for age, gender, CVC body location, and hospital unit (odds ratio, 0.15; 95% confidence interval, 0.06-0.34; P < .001). According to the multivariate regression, days to removal of lines with CLISA score of 2 or 3 was 3.19 days faster after the intervention (P < .001). Also, line dwell time decreased 37.1% from a mean of 14 days (standard deviation [SD], 10.6) to 8.8 days (SD, 9.0) (P < .001). Device utilization ratios decreased 9% from 0.64 (SD, 0.08) to 0.58 (SD, 0.06) (P = .039). The CLISA score creates a common language for assessing line infection risk and successfully promotes high compliance with best practices in timely line removal.
Identifiants
pubmed: 31699181
pii: S0899823X19002915
doi: 10.1017/ice.2019.291
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
59-66Subventions
Organisme : AHRQ HHS
ID : R01 HS024424
Pays : United States